Subcutaneous Drug Delivery Market, By Technology (Syringes, Pens, Patches And Others), By Distributi

Published Date: February 2020 | Report Code : HC2061574

X

The global subcutaneous drug delivery market is expected to reach USD 19.13 billion by 2028 at a CAGR of 7.1% during the forecast period.

According to the World Health Organization (WHO), there are quite 422 million of the adult population of diabetes within the US which represents the many population and with increasing diagnosis rate subcutaneous drug delivery market further expected witness growth. Increasing treatment-seeking rates and spreading awareness about possible treatment options for diabetes is predicted to fuel the subcutaneous drug delivery market. Owing to self-administered drug, administration of injectable moves increasingly from practitioner offices and healthcare facilities to patient homes. As subcutaneous route of administration is effective alternative to intravenous route of administrations it's expected to future drive the expansion of subcutaneous drug delivery market. With the arrival of one injector device, auto-injector, mechanical pumps and progress in digital medicine, it's anticipated to grow within the subcutaneous drug delivery market. Also, technical advancement like Bluetooth connectivity of glucometer also alphanumeric display and touch screen features in devices are expected to spice up the demand for subcutaneous drug delivery market during the forecast period. However, the high cost of subcutaneous drug delivery may hamper the expansion subcutaneous drug delivery market.

Key Factors Impacting the Growth of Subcutaneous Drug Delivery Market:

  • Increase in number of adult population of diabetes.
  • Increasing treatment-seeking rates and spreading awareness about possible treatment.

The subcutaneous drug delivery market segmentation is based on type, distribution channel, and region.

Technology Outlook:

Based on technology, the market is segmented into syringes, pens, patches and others. The syringes segment is going to dominate the global subcutaneous drug delivery market in 2018 owing to increase in demand for single-use syringes, which expected to widely reduce the rates of cross contamination in the recent years. However, the patches segmented is expected to grow at the highest growth rate in the subcutaneous drug delivery market in the future.

Distribution Channel Outlook

Based on application, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment is expected to dominate the market in 2018 and expected to dominate the market during the forecast period.

Regional Outlook:

Based on the region, the global subcutaneous drug delivery market has been segmented by North America, Western Europe, Eastern Europe, Asia Pacific, Middle East, & Rest of the World. In 2018, North America is attributed to holding the highest market share in terms of value in the global subcutaneous drug delivery market. The growth of the region is primarily driven owing to the presence of major leading manufacturers and advanced healthcare infrastructure. Also, North America is the most productive subcutaneous drug delivery market in the coming years. Moreover, Europe is expected to hold the second-highest market share in the subcutaneous drug delivery market owing to the higher treatment success rate. Furthermore, Asia-Pacific is expected to hold the highest growth rate in the global market owing to the presence of emerging economies such as India and China coupled with improving awareness among the consumers about treatment options.

Competitive Landscape

The leading companies in the market are focused on the product development as well as the acquisition in the market to enhance the market share in the global market during the forecast period. This also expected to fuel the market growth in the coming years. The key leading players in the global subcutaneous drug delivery market include Insulet Corporation, Becton Dickinson Company, Consort Medical, West pharmaceuticals services Inc., Ypsomed AG, Elcam Medical, Sc Pharmaceuticals Inc., Steady Med Ltd, Amgen Inc., and Sensile medical AG.

This report also includes the profiles of key subcutaneous drug delivery market companies along with their SWOT analysis and market strategies. In addition, these competitive landscapes provide a detailed description of each company including future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launch, new product developments, and other latest industrial developments.

Key Developments in Subcutaneous Drug Delivery Market:

  • In November 2018, Wearable subcutaneous drug delivery become available for the treatment of different health conditions. The drug developers and manufacturers have increasingly pursued packaging and delivery options to make simplify the administration process and increase the efficiency and reliability with which the drug can be introduced into the patient.

What Does This Report Provide?

This report provides a detailed understanding of the global subcutaneous drug delivery market from qualitative and quantitative perspectives during the forecast period. The report also provides dynamic indicators with potential impact on the market during the forecast period and an in-depth analysis of the leading companies operating in the market.

Market Segmentation:

Based on the Technology

  • Syringes
  • Pens
  • Patches
  • Others
  • Instrument

Based on the Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region:

North America

  • By Country (US, Canada, Mexico)
  • By Component
  • By Distribution Channel

Western Europe

  • By Country (Germany, UK, France, Italy, Spain, Rest of Western Europe)
  • By Component
  • By Distribution Channel

Eastern Europe

  • By Country (Russia, Turkey, Rest of Eastern Europe)
  • By Component
  • By Distribution Channel

Asia Pacific

  • By Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)
  • By Component
  • By Distribution Channel

Middle East

  • By Country (UAE, Saudi Arabia, Qatar, Iran, Rest of Middle East)
  • By Component
  • By Distribution Channel

Rest of the World

  • By Region (South America, Africa)
  • By Offering
  • By Component
  • By Distribution Channel

Reasons to Buy This Report:

  • Market size estimation of the subcutaneous drug delivery market on a regional and global basis
  • Unique research Usage for market size estimation and forecast
  • Profiling of major companies operating in the market with key developments
  • Broad scope to cover all the possible segments helping every stakeholder in the market

Customization:

We provide customization of the study to meet specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country

For more information, contact: [email protected]

License Offering

Single User (PDF)

3850

Multi User (PDF)

5150

Enterprise User (PDF)

7650

Get Regional Report @ USD 2000 Only

Your personal details are secure. Privacy Policy

Buy Chapters of Sections

Avail customized purchase options to meet your exact research needs.

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities
Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision

Recommendations

Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements

15% Free Customization

Share your Requirements

Questions?  Speak to an Analyst

Your personal details are secure. Privacy Policy